JYMed ya aiwatar da ingantaccen tsarin gudanarwa mai inganci, yana samun takaddun shaida guda uku don ci gaba da ba da samfura da sabis waɗanda suka dace da ka'idodin duniya. Nasarar takaddun shaida na ISO 9001 ya nuna cewa kamfanin yana da ƙayyadaddun matakai da ka'idoji don gudanarwa na cikin gida, yana ba da damar sarrafa haɗarin inganci mai inganci, rage kurakurai da sharar gida, da haɓaka ingantaccen aiki.

Yayin da yake neman fa'idodin tattalin arziki, kamfanin ya ci gaba da bin ka'idoji da ka'idoji na kare muhalli. Samun takardar shedar ISO 14001 yana nuna jajircewar JYMed Peptide na ci gaba mai dorewa, aiwatar da ayyukan da suka dace da muhalli, da kuma cika nauyin da ya rataya a wuyanta na zamantakewa a matsayin babbar sana'ar fasaha a masana'antar biopharmaceutical.

Lafiya da amincin ma'aikata sun kasance babban fifiko a JYMed Peptide. Daga ƙididdigar haɗari zuwa haɓaka kayan aiki, daga horar da ma'aikata zuwa tsarin amsa gaggawa, kamfanin yana tabbatar da cewa kowane ma'aikaci zai iya aiki a cikin yanayi mai aminci da lafiya. Samun takaddun shaida na ISO 45001 kwanan nan yana nuna girmamawar JYMed Peptide ga darajar rayuwa kuma yana nuna cewa kamfanin ya kai matakin ci gaba na duniya a cikin kula da lafiyar ma'aikata da aminci.

Game da JYMed

JYMed babban kamfani ne na samar da magunguna da ke mayar da hankali kan bincike mai zaman kansa, haɓakawa, samarwa, da kasuwancin samfuran tushen peptide. Har ila yau, muna ba da cikakkiyar sabis na CDMO, samar da hanyoyin magance peptide na musamman ga abokan ciniki na duniya na magunguna, kayan kwalliya, da na dabbobi.

Fayil ɗin samfurin mu ya haɗa da dozin na peptide APIs, tare da ainihin samfuran kamar Semaglutide da Terlipressin bayan sun sami nasarar kammala takaddun FDA DMF na Amurka.

Mallakar mu gabaɗaya, Hubei JXBio Pharmaceutical Co., Ltd., tana gudanar da layukan samar da peptide API na zamani wanda aka gina don dacewa da ka'idojin cGMP wanda FDA ta Amurka ta kafa, da kuma NMPA ta China. Ginin yana dauke da manyan layukan samar da matukan jirgi guda 10, wanda ke da goyan bayan tsarin kula da ingancin magunguna (QMS) da ingantaccen tsarin kiwon lafiya da kare muhalli (EHS).

JXBio ya wuce binciken bin ka'idojin GMP da FDA ta Amurka da kuma NMPA ta kasar Sin suka amince da su, kuma manyan kamfanonin harhada magunguna na duniya sun amince da su saboda kyawunsa a gudanar da EHS - shaida ga sadaukarwarmu ga inganci, aminci, da kula da muhalli.
Manyan Yankunan Kasuwanci
• Rijistar duniya da yarda don APIs peptide
• peptides na dabbobi da kayan kwalliya
• Ayyukan peptide na al'ada (CRO, CMO, OEM)
• Peptide-drug conjugates (PDCs), gami da:
• Peptide-radionuclide
• Peptide-kananan kwayoyin halitta
• Peptide-protein
• Magungunan Peptide-RNA

BABBAN KAYANA

Don ƙarin cikakkun bayanai kan samfuranmu, da fatan za a tuntuɓe mu.
API ɗin Duniya da Ƙwararrun Tambayoyi: Tel No.: +86-15013529272;
API ɗin Rajista & Sabis na CDMO (Kasuwar EU ta Amurka): +86-15818682250
E-mail: jymed@jymedtech.com
Adireshin: benaye 8 & 9, Ginin 1, Shenzhen Biomedical Innovation Industrial Park, 14 Jinhui Road, Kengzi Subdistrict, Pingshan District, Shenzhen